banner

Products

Anti Estrogen Apis Raw Steroid Powder Trilostane CAS 13647-35-3 for Breast Cancer

Anti Estrogen Apis Raw Steroid Powder Trilostane CAS 13647-35-3 for Breast Cancer

Anti Cancer Pharmaceutical Trilostane CAS 13647-35-3 hormone Raw Powder Physical Characters and specifications Product I
SHARE

Description

Basic Info
Model NO. top quality
CAS No. 13647-35-
Einecs No. 237-133-0
Mf C20h27no3
MW 329.43
Appearance White Powder
MOQ 100g
Storge 2-8 Degree
Exp. 24 Months
Transport Package Per Box
Specification 100g/bag
Trademark senwayer
Origin China
HS Code 2601111000
Production Capacity 10kg Per Month
Product Description

Anti Cancer Pharmaceutical Trilostane CAS 13647-35-3 hormone Raw Powder

Physical Characters and specifications

Product nameTrilostane
CAS No.13647-35-3
Molecular FormulaC20H27NO3
Molecular weight329.43
EINECS NO.237-133-0
Grade StandardMedicine Grade
COAAvaliable

ItemSpecifications
AppearanceWhite to tan powder.
Purity99%min
Melting point264ºC
Boiling point467.02ºC(rough estimate)
Density1.1213 (rough estimate)
Specific rotation25 +137.4°
Refractive index1.5614 (estimate)
SolubilityDMSO: ≥17mg/mL
Storage condition-20ºC Freezer
Shelf life2 years

Product Introduction

Trilostane is an inhibitor of isoforms 3β-HSD and 3β-HSD2 of the enzyme 3β-hydroxysteroid dehydrogenase, which plays a role in adrenal steroid biosynthesis. Investigators believe that Arg195 in 3∫-HSD versus Pro195 in 3β-HSD2 attributes to the competitive inhibition of 3β-HSD, but not 3β-HSD2 by Trilostane.

Function and Application

Trilostane is used in the treatment of Cushing's syndrome. It is normally used in short-term treatment until permanent therapy is possible.
Trilostane blocks an enzyme involved in the production of several steroids including cortisol. Inhibiting this enzyme inhibits the production of cortisol. In Cushing's syndrome, the adrenal gland overproduces steroids. Although steroids are important for various functions of the body, too much can cause problems. Trilostane reduces the amount of steroids produced by the adrenal gland.
Trilostane produces suppression of the adrenal cortex by inhibiting enzymatic conversion of steroids by 3-beta-hydroxysteroid dehydrogenase/delta 5,4 ketosteroid isomerase, thus blocking synthesis of adrenal steroids.

For the treatment of post-menopausal women who have hormone-selective cancers that have spread beyond the breast, the medicine slows disease progression in two ways. Hormone-sensitive breast cancer, estrogen through the role of two kinds of receptors to promote cancer cell growth, estrogen receptor A like cancer accelerator, estrogen receptor beta is the brake. Modrenal enhances the estrogen receptor beta-estrogen adsorption, while reducing the role of the estrogen receptor a. At the same time it also acts on another site of cellular DNA AP1 to reduce cell proliferation.

Notes:

Side effect:Symptoms of overdose include darkening of skin, drowsiness or tiredness, loss of appetite, mental depression, skin rash, and/or vomiting.


Anti Estrogen Apis Raw Steroid Powder Trilostane CAS 13647-35-3 for Breast Cancer

Anti Estrogen Apis Raw Steroid Powder Trilostane CAS 13647-35-3 for Breast Cancer

Anti Estrogen Apis Raw Steroid Powder Trilostane CAS 13647-35-3 for Breast Cancer

Anti Estrogen Apis Raw Steroid Powder Trilostane CAS 13647-35-3 for Breast Cancer

Anti Estrogen Apis Raw Steroid Powder Trilostane CAS 13647-35-3 for Breast Cancer

 

Our Contact